Safety and Tolerability of Manual Push Administration of Subcutaneous IgPro20 at High Infusion Rates in Patients with Primary Immunodeficiency: Findings from the Manual Push Administration Cohort of the HILO Study

PURPOSE: To evaluate the safety and tolerability of IgPro20 manual push (also known as rapid push) infusions at flow rates of 0.5–2.0 mL/min. METHODS: Patients with primary immunodeficiency (PID) with previous experience administering IgPro20 (Hizentra(®), CSL Behring, King of Prussia, PA, USA) were...

Descripción completa

Detalles Bibliográficos
Autores principales: Cowan, Juthaporn, Bonagura, Vincent R., Lugar, Patricia L., Maglione, Paul J., Patel, Niraj C., Vinh, Donald C., Hofmann, Jutta H., Praus, Michaela, Rojavin, Mikhail A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846525/
https://www.ncbi.nlm.nih.gov/pubmed/33025378
http://dx.doi.org/10.1007/s10875-020-00876-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846525/
https://www.ncbi.nlm.nih.gov/pubmed/33025378
http://dx.doi.org/10.1007/s10875-020-00876-6

Ejemplares similares